At the Royal Society of Chemistry, we’re proud to be welcoming two new cohorts of early-stage ventures to the
Change Makers venture acceleration programme in 2025. These are start-ups with big ambitions—using deep tech chemistry to tackle some of the world’s most pressing challenges, from climate change to human health.
We run our programme in tailored cohorts, allowing us to group ventures by their technology focus and stage of development and enabling us to deliver customised support through masterclasses, mentoring, investment support, and access to legal, IP, and insurance experts. Just as importantly, it helps founders build a community with their peers.
Explore our cleantech cohort now!
Our cleantech cohort—now underway—includes start-ups working on everything from pollution monitoring to next-generation battery materials. Since joining, they’ve participated in sessions on product development, value propositions, and market entry, and they will soon be matched with our deep tech chemistry Venture Mentors to help shape their scale-up strategy.
As they progress, they’ll continue through a masterclass series covering team building, lab infrastructure, pitching, and innovation leadership, as well as connecting them with our investment expertise. With climate and sustainability at the core of their work, these ventures are aiming to have a real and lasting impact on the planet.
Join us in welcoming them and wishing them luck on their journeys:
AilArian Ltd
Kodiaq Technologies Limited
Mantisonix Ltd
Mode Labs Ltd
R3V Tech Ltd
Repolywise Limited
Solveteq Ltd
Sustainable Sailing Ltd
Human Health Cohort: Now Open for Applications!
Our second 2025 cohort—focused on Chemistry in human health—is now
open for applications until 29 August 2025 . We're looking for early-stage start-ups that are innovating in areas like drug discovery, diagnostics, biotechnology, and pharmaceuticals.
Previous health-focused Change Makers include companies like
EnsiliTech, enabling vaccine transport at higher temperatures, and
Apeikon Therapeutics, targeting difficult-to-reach tumours with ultrasound and nanoparticles. They both recently featured in
our case study series, if you would like to learn more about deep tech chemistry innovation in health solutions.
If you know a venture that’s combining chemistry and innovation to improve human health,
tell them to get in touch. And if you're part of the wider innovation ecosystem, help us spread the word by liking and sharing our updates on LinkedIn.